-+ 0.00%
-+ 0.00%
-+ 0.00%

CRISPR THERAPEUTICS AG - CTX310 WELL TOLERATED WITH NO TREATMENT-RELATED SERIOUS ADVERSE EVENTS

Reuters·11/09/2026 14:16:12

Please log in to view news